Artificial intelligence in the diagnosis and management of gynecologic cancer
Authors:
Top Cited Papers
Open Access
- 25 April 2025
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 171 (S1) , 199-209
Abstract
Gynecologic cancers affect over 1.2 million women globally each year. Early diagnosis and effective treatment are essential for improving patient outcomes, yet traditional diagnostic methods often encounter limitations, particularly in low‐resource settings. Artificial intelligence (AI) has emerged as a transformative tool that enhances accuracy and efficiency across various aspects of gynecologic oncology, including screening, diagnosis, and treatment. This review examines the current applications of AI in gynecologic cancer care, focusing on areas such as early detection, imaging, personalized treatment planning, and patient monitoring. Based on an analysis of 75 peer‐reviewed articles published between 2017 and 2024, we highlight AI's contributions to cervical, ovarian, and endometrial cancer management. AI has notably improved early detection, achieving up to 95% accuracy in cervical cancer screening through AI‐enhanced Pap smear analysis and colposcopy. For ovarian and endometrial cancers, AI‐driven imaging and biomarker detection have enabled more personalized treatment approaches. In addition, AI tools have enhanced precision in robotic‐assisted surgery and radiotherapy, and AI‐based histopathology has reduced diagnostic variability. Despite these advancements, challenges such as data privacy, bias, and the need for human oversight must be addressed. The successful integration of AI into clinical practice will require careful consideration of ethical issues and a balanced approach that incorporates human expertise. Overall, AI presents significant potential to improve outcomes in gynecologic oncology, particularly in bridging healthcare gaps in resource‐limited settings.Keywords
This publication has 70 references indexed in Scilit:
- Exploring the role of artificial intelligence, large language models: Comparing patient‐focused information and clinical decision support capabilities to the gynecologic oncology guidelinesInternational Journal of Gynecology & Obstetrics, 2024
- Role of artificial intelligence in digital pathology for gynecological cancersComputational and Structural Biotechnology Journal, 2024
- Artificial intelligence performance in image-based ovarian cancer identification: A systematic review and meta-analysiseClinicalMedicine, 2022
- Artificial intelligence to identify genetic alterations in conventional histopathologyThe Journal of Pathology, 2022
- Artificial intelligence in gynecologic cancers: Current status and future challenges – A systematic reviewArtificial Intelligence in Medicine, 2021
- 68Ga-FAPI-PET/CT in patients with various gynecological malignanciesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Feasibility of MRI-based radiomics features for predicting lymph node metastases and VEGF expression in cervical cancerEuropean Journal of Radiology, 2021
- The artificial intelligence‐assisted cytology diagnostic system in large‐scale cervical cancer screening: A population‐based cohort study of 0.7 million womenCancer Medicine, 2020
- The ethical, legal and social implications of using artificial intelligence systems in breast cancer careThe Breast, 2020
- The Role of Stereotactic Ablative Body Radiotherapy in Gynaecological Cancers: A Systematic ReviewClinical Oncology, 2017